CALIFORNIA LIFE SCIENCES for CALIFORNIA LIFE SCIENCES
What was lobbied
7 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Oppose medical device tariffs Support data exclusivity provisions in USMCA / Oppose proposals to reduce data exclusivity
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER NIETO CAREY | — |
| MOLLY FISHMAN New | — |
Health Issues HCR
Support FDA user fee programs and review process consistency and predictability. Support PAHPA reauthorization. Support policy improvements to address antimicrobial resistance.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER NIETO CAREY | — |
| MOLLY FISHMAN New | — |
Medical/Disease Research/Clinical Labs MED
Support NIH research funding Support implementation of 21st Century Cures Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER NIETO CAREY | — |
| MOLLY FISHMAN New | — |
Copyright/Patent/Trademark CPT
Address concerns with provisions of patent litigation reform, including inter partes review Support STRONGER Patents Act Support Hatch Waxman Integrity Act Oppose "march-in" rights and "compulsory licensing" proposals
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER NIETO CAREY | — |
| MOLLY FISHMAN New | — |
Taxation/Internal Revenue Code TAX
Support repeal of medical device tax Support orphan drug tax credit and R & D tax credit
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER NIETO CAREY | — |
| MOLLY FISHMAN New | — |
Medicare/Medicaid MMM
Address concerns with changes to Medicare Part B and Part D programs, and Hospital Outpatient Prospective Payment System Address concerns with Medicare Advantage step therapy proposal and Medicare Part D protected classes proposal Oppose changes to Medicare Advantage and Part D prescription drug benefit Support reforms to enable Value Based Healthcare Oppose International Pricing Index/reference pricing in Medicare Part B Support Ensuring Patient Access to/coverage of critical breakthrough products via Hospital Inpatient Prospective Payment System proposed rule and legislation Oppose Medicare negotiating proposals that include compulsory licensing
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER NIETO CAREY | — |
| MOLLY FISHMAN New | — |
Budget/Appropriations BUD
Labor/HHS/Ed Appropriations: NIH, antimicrobial resistance, biodefense/pandemic, science/math education, and strategic stockpile funding and preparation FDA Appropriations; PTO Appropriations
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER NIETO CAREY | — |
| MOLLY FISHMAN New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.